Australia · Delayed Price · Currency is AUD Imricor Medical Systems Statistics
Total Valuation
ASX:IMR has a market cap or net worth of AUD 706.39 million. The enterprise value is 658.05 million.
| Market Cap | 706.39M |
| Enterprise Value | 658.05M |
Important Dates
The last earnings date was Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:IMR has 358.57 million shares outstanding. The number of shares has increased by 17.63% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 358.57M |
| Shares Change (YoY) | +17.63% |
| Shares Change (QoQ) | +4.24% |
| Owned by Insiders (%) | 7.87% |
| Owned by Institutions (%) | 19.54% |
| Float | 308.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4,069.73 |
| PB Ratio | 16.81 |
| P/TBV Ratio | 16.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.72 |
| Quick Ratio | 1.67 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.37 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -143.12% and return on invested capital (ROIC) is -30.88%.
| Return on Equity (ROE) | -143.12% |
| Return on Assets (ROA) | -26.53% |
| Return on Invested Capital (ROIC) | -30.88% |
| Return on Capital Employed (ROCE) | -83.08% |
| Weighted Average Cost of Capital (WACC) | 6.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | 2.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.85% in the last 52 weeks. The beta is 0.48, so ASX:IMR's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +44.85% |
| 50-Day Moving Average | 1.89 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 52.33 |
| Average Volume (20 Days) | 397,165 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IMR had revenue of AUD 173,571 and -53.94 million in losses. Loss per share was -0.18.
| Revenue | 173,571 |
| Gross Profit | -4.03M |
| Operating Income | -39.63M |
| Pretax Income | -53.94M |
| Net Income | -53.94M |
| EBITDA | -38.53M |
| EBIT | -39.63M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 97.52 million in cash and 49.18 million in debt, with a net cash position of 48.34 million or 0.13 per share.
| Cash & Cash Equivalents | 97.52M |
| Total Debt | 49.18M |
| Net Cash | 48.34M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 42.02M |
| Book Value Per Share | 0.12 |
| Working Capital | 42.07M |
Cash Flow
In the last 12 months, operating cash flow was -34.68 million and capital expenditures -1.15 million, giving a free cash flow of -35.84 million.
| Operating Cash Flow | -34.68M |
| Capital Expenditures | -1.15M |
| Depreciation & Amortization | 1.06M |
| Net Borrowing | n/a |
| Free Cash Flow | -35.84M |
| FCF Per Share | -0.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | -22,830.51% |
| Pretax Margin | -31,076.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:IMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.63% |
| Shareholder Yield | -17.63% |
| Earnings Yield | -7.64% |
| FCF Yield | -5.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for ASX:IMR is 2.96, which is 50.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.96 |
| Price Target Difference | 50.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 372.66% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:IMR has an Altman Z-Score of 0.51 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.51 |
| Piotroski F-Score | 1 |